A nasal swab containing a test sample is mixed with a simple lab test. It...
A nasal swab containing a test sample is mixed with a simple lab test. It contains a liquid mixed with gold nanoparticles attached to a molecule that binds to the novel coronavirus. If the virus is present, the gold nanoparticles turns the solution a deep blue color (bottom of the tube) and a precipitation is noticed. If it is not present, the solution retains its original purple color.
Source: University of Maryland School of Medicine

Nanotechnology provides rapid visual detection of COVID-19

Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis.

“Based on our preliminary results, we believe this promising new test may detect RNA material from the virus as early as the first day of infection. Additional studies are needed, however, to confirm whether this is indeed the case,” said study leader Dipanjan Pan, PhD, Professor of Diagnostic Radiology and Nuclear Medicine and Pediatrics at the UMSOM.

Once a nasal swab or saliva sample is obtained from a patient, the RNA is extracted from the sample via a simple process that takes about 10 minutes. The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein. This protein is part of the genetic sequence that is unique to the novel coronavirus. When the biosensor binds to the virus’s gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue.

“The accuracy of any COVID-19 test is based on being able to reliably detect any virus. This means it does not give a false negative result if the virus actually is present, nor a false positive result if the virus is not present,” said Dr. Pan. “Many of the diagnostic tests currently on the market cannot detect the virus until several days after infection. For this reason, they have a significant rate of false negative results.”

Dr. Pan created a company called VitruVian Bio to develop the test for commercial application. He plans to have a pre-submission meeting with the U.S. Food and Drug Administration (FDA) within the next month to discuss requirements for getting an emergency use authorization for the test. New FDA policy allows for the marketing of COVID-19 tests without requiring them to go through the usual approval or clearance process. These tests do, however, need to meet certain validation testing requirements to ensure that they provide reliable results.

“This RNA-based test appears to be very promising in terms of detecting the virus. The innovative approach provides results without the need for a sophisticated laboratory facility,” said study co-author Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at UMSOM.

Although more clinical studies are warranted, this test could be far less expensive to produce and process than a standard COVID-19 lab test; it does not require laboratory equipment or trained personnel to run the test and analyze the results. If this new test meets FDA expectations, it could potentially be used in daycare centers, nursing homes, college campuses, and work places as a surveillance technique to monitor any resurgence of infections.

Subscribe to our newsletter

Related articles

Quantum nanodiamonds help detect disease earlier

Quantum nanodiamonds help detect disease earlier

The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV.

COVID-19 rapid test has successful lab results

COVID-19 rapid test has successful lab results

Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results.

Holographic imaging to detect viruses

Holographic imaging to detect viruses

A new approach using holographic imaging to detect both viruses and antibodies has the potential to aid in medical diagnoses and, specifically, those related to the COVID-19 pandemic.

AI-enabled rapid diagnostic test for COVID-19

AI-enabled rapid diagnostic test for COVID-19

Scientists have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

A novel swab design to augment COVID-19 testing

A novel swab design to augment COVID-19 testing

Scientists have developed a novel test swab that can be 3D printed using inexpensive, widely available materials and speedily assembled in a range of fabrication settings.

A biosensor for the COVID-19 virus

A biosensor for the COVID-19 virus

Researchers have developed a novel sensor for detecting the new coronavirus. In future it could be used to measure the concentration of the virus in the environment.

'Organ-on-a-chip' finds out how COVID-19 invades our bodies

'Organ-on-a-chip' finds out how COVID-19 invades our bodies

In order for a COVID-19 vaccine and antiviral drugs to be developed, scientists first need to understand why this virus spreads so easily and quickly, and why it invades our bodies with seemingly little resistance from our immune system.

A robotic COVID-19 testing lab

A robotic COVID-19 testing lab

Scientists are creating from scratch a diagnostic lab with the capability to process more than 1,000 patient samples per day.

AI, App provide at-home assessment of coronavirus risk

AI, App provide at-home assessment of coronavirus risk

A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they've been in about a minute.

Popular articles